Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 303, Issue 12, 2012, Pages

  Tanaka, Tetsu ^a   Ogawa, Masahito ^b   Suzuki, Jun Ichi ^b   Sekinishi, Asuka ^a   Itai, Akiko ^c   Hirata, Yasunobu ^b   Nagai, Ryozo ^b   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Inst of Medicinal Molecular Design   (Japan)

Author keywords

Cardiac hypertropy; I B kinase; Nuclear factor B

Indexed keywords

GELATINASE A; I KAPPA B; IMD 1041; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN INHIBITOR; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART STRESS; HEART WEIGHT; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA, THORACIC; APOPTOSIS; BENZAMIDES; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FIBROSIS; HEART; HEART VENTRICLES; I-KAPPA B KINASE; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MYOCARDIUM; NF-KAPPA B; PHOSPHORYLATION; VASOCONSTRICTION;

EID: 84871315353     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00290.2012     Document Type: Article

References (19)

1. Del Re DP, Matsuda T, Zhai P, Gao S, Clark GJ, Van Der Weyden L, Sadoshima J. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest 120: 3555-3567, 2010.
2. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
3. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE, Ertl G, Bauersachs J. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc Res 57: 749-756, 2003.
4. Fukuda S, Horimai C, Harada K, Wakamatsu T, Fukasawa H, Muto S, Itai A, Hayashi M. Aldosterone-induced kidney injury is mediated by NFκB activation. Clin Exp Nephrol 15: 41-49, 2011.
5. Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, Yong SL, Mahajan A, Wang Q, Sen S. Prevention of cardiac hypertrophy and heart failure by silencing of NF-κB. J Mol Biol 375: 637-649, 2008.
6. Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, Mizote I, Taneike M, Oka T, Tamai T, Oyabu J, Uno Y, Matsumura Y, Nishida K, Suzuki K, Kogo M, Hori M, Otsu K. The IκB kinase β/nuclear factor κB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res 105: 70-79, 2009.
7. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE. Minimally invasive aortic banding in mice: effects of altered cardiomyo-cyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285: H1261-H1269, 2003.
8. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2: 725-734, 2002.
9. Li Y, Ha T, Gao X, Kelley J, Williams DL, Browder IW, Kao RL, Li C. NF-κB activation is required for the development of cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol 287: H1712-H1720, 2004.
10. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload. Hypertension 47: 711-717, 2006.
11. Morisco C, Seta K, Hardt SE, Lee Y, Vatner SF, Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem 276: 28586-28597, 2001.
12. Onai Y, Suzuki J, Maejima Y, Haraguchi G, Muto S, Itai A, Isobe M. Inhibition of NF-κB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. Am J Physiol Heart Circ Physiol 292: H530-H538, 2007.
13. Selvetella G, Hirsch E, Notte A, Tarone G, Lembo G. Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63: 373-380, 2004.
14. Suzuki J, Ogawa M, Maejima Y, Isobe K, Tanaka H, Sagesaka Y, Isobe M. Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats. J Mol Cell Cardiol 42: 432-440, 2007.
15. Suzuki J, Ogawa M, Sagesaka YM, Isobe M. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc Res 69: 272-279, 2006.
16. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120: 254-265, 2010.
17. Valen G, Yan ZQ, Hansson GK. Nuclear factor-βB and the heart. J Am Coll Cardiol 38: 307-314, 2001.
18. Wakatsuki T, Schlessinger J, Elson E. The biochemical response of the heart to hypertension and exercise. Trends Biochem Sci 29: 609-617, 2004.
19. Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase-2 and-9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J Biol Chem 279: 39513-39519, 2004.